FAQ on Izotropic Corporation's IzoView Breast CT Imaging System
Summary
What is the IzoView Breast CT Imaging System?
The IzoView Breast CT Imaging System is a medical device developed by Izotropic Corporation for breast cancer detection and treatment, offering true 3D, ultra-high-resolution imaging without the need for breast compression.
How does IzoView compare to current breast imaging technologies?
IzoView bridges the gap between digital breast tomosynthesis and MRI, delivering 100x greater spatial resolution than MRI at a lower cost and with shorter scan times, especially beneficial for women with dense breast tissue.
Who developed the IzoView Breast CT Imaging System?
The IzoView Breast CT Imaging System was developed by Izotropic Corporation under a global license from UC Davis.
What are the benefits of the IzoView Breast CT Imaging System?
The benefits include improved screening, diagnosis, and treatment planning for breast cancer, particularly in women with dense breast tissue, due to its high-resolution imaging and lack of breast compression.
Where can I find more information about Izotropic Corporation?
More information can be found on Izotropic Corporation’s website at izocorp.com and by reviewing its profile on SEDAR at sedarplus.ca.
What is TechMediaWire?
TechMediaWire is a specialized communications platform focusing on pioneering public and private companies driving the future of technology, part of the Dynamic Brand Portfolio within the InvestorBrandNetwork.
How can I receive alerts from TechMediaWire?
To receive SMS alerts from TechMediaWire, text ‘TECH’ to 888-902-4192 (U.S. Mobile Phones Only).
Where can I view the full press release about IzoView?
The full press release can be viewed at https://ibn.fm/NbLB2.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 124458